Akari Therapeutics Plc Ret. on assets
What is the Ret. on assets of Akari Therapeutics Plc?
The Ret. on assets of Akari Therapeutics Plc is -141.94%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NASDAQ compared to Akari Therapeutics Plc
What does Akari Therapeutics Plc do?
akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.
Companies with ret. on assets similar to Akari Therapeutics Plc
- Pacific Ridge Exploration has Ret. on assets of -142.70%
- CurrencyWorks has Ret. on assets of -142.63%
- AgEagle Aerial Systems has Ret. on assets of -142.51%
- Theralase Technologies has Ret. on assets of -142.49%
- Midpoint has Ret. on assets of -142.22%
- Sonnet BioTherapeutics Inc has Ret. on assets of -142.13%
- Akari Therapeutics Plc has Ret. on assets of -141.94%
- Appreciated Media has Ret. on assets of -141.90%
- Appreciated Media has Ret. on assets of -141.90%
- Mednow has Ret. on assets of -141.86%
- Esports Mogul has Ret. on assets of -141.86%
- AIM ImmunoTech Inc has Ret. on assets of -141.74%
- Bee Vectoring Technologies International has Ret. on assets of -141.67%